ALAM JOHN J
Company insiders · CEO & President · Director · 10% owner · CervoMed Inc.
- Reported transaction lines
- 2
- Buy lines
- 2
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-112
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| ALAM JOHN J CEO & President · Director · 10% owner · CervoMed Inc. | CRVO CervoMed Inc. | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 1584078 · SEC code covers open-market or private transactions · Shares purchased in open-market transactions. · Includes (i) 1,471,578 shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors, and (ii) 112,500 shares held by the John J. Alam Roth IRA. | 2026-11-18 | 2026-11-19 | ≈ $116,768.07 76,319 shares/units | SEC 4 |
| ALAM JOHN J CEO & President · Director · 10% owner · CervoMed Inc. | CRVO CervoMed Inc. | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 1507759 · SEC code covers open-market or private transactions · Shares purchased in open-market transactions. · Includes (i) 1,471,578 shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors, and (ii) 112,500 shares held by the John J. Alam Roth IRA. | 2026-11-18 | 2026-11-19 | ≈ $35,853.03 23,681 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.